Drug search by name

Segluromet and Renal impairment

Result of checking the interaction of drug Segluromet and disease Renal impairment for safety when used together.

Check result:

Segluromet <> Renal impairment

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of ertugliflozin is contraindicated in patients with severe renal impairment, end-stage renal disease, or dialysis. The use of ertugliflozin in patients with moderate renal impairment did not have improvement in glycemic control, and had increased risks for renal impairment, renal-related adverse reactions and volume depletion adverse reactions; therefore, its use is not recommended in this population. No dosage adjustment or increased monitoring is needed in patients with mild renal impairment. Renal function should be evaluated prior to initiating treatment with ertugliflozin and periodically thereafter.

Segluromet

Generic Name: ertugliflozin / metformin

Brand Name: Segluromet

Synonyms: n.a.

What is Segluromet?